Inscripta merged with Manus in April 2025 to establish a unique end-to-end platform for scalable development, biomanufacturing, and commercialization of bioalternative products. By combining Inscripta’s advanced whole-genome engineering technologies with Manus’ proven cell factory engineering platform, biomanufacturing expertise, and commercialization capabilities, the merged company – Manus – is uniquely positioned to deliver commercial momentum and scaled profitability in next-generation industrial biotechnology.
Looking for a particular Inscripta, Inc. employee's phone or email?
Inscripta, Inc. Questions
The Inscripta, Inc. annual revenue was $29.8 million in 2026.
Ron McGrath is the CFO of Inscripta, Inc..
46 people are employed at Inscripta, Inc..
Inscripta, Inc. is based in Boston, Massachusetts.
The NAICS codes for Inscripta, Inc. are [541, 54, 5417].
The SIC codes for Inscripta, Inc. are [87, 873].
Top Inscripta, Inc. Employees
-
Ron McGrath
Chief Financial Officer at Inscripta, Inc.
Poway, CA, US25+ -
Michael Seater
Head of Finance at Inscripta, Inc.
Walnut Creek, CA, US11 -
Scott Frykman
VP of Process Sciences at Inscripta, Inc.
San Francisco, CA, US25+ -
45+
Related Companies
